Nursing and Health Professions
Adult
14%
Adverse Event
28%
Chronic Hepatitis C
14%
Death
28%
Decompensated Liver Cirrhosis
100%
Dose
28%
Hepatitis C
100%
Imaging
14%
Inpatient
100%
Liver Cell Carcinoma
14%
Liver Cirrhosis
14%
Liver Disease
14%
Patient
100%
Patient Population
14%
Ribavirin
100%
Screening
14%
Sofosbuvir
14%
Sustained Virologic Response
28%
Velpatasvir
14%
Virus RNA
14%
Weight
28%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
40%
Chronic Hepatitis C
20%
Death
40%
Decompensated Liver Cirrhosis
100%
Hepatitis C
20%
Hepatitis C Virus
100%
Liver Cell Carcinoma
20%
Liver Cirrhosis
20%
Liver Disease
20%
Ribavirin
100%
Sofosbuvir
20%
Sofosbuvir Plus Velpatasvir
100%
Velpatasvir
20%
Virus RNA
20%
Biochemistry, Genetics and Molecular Biology
Dose
33%
Hepatitis C Virus
100%
Ribavirin
100%
RNA Virus
16%
Screening
16%
Weight
33%